A 32-year-old woman with major depressive disorder on sertraline 100 mg daily presents to the emergency department with agitation, tremor, hyperreflexia, and a core temperature of 38.5°C. She admits to starting phenelzine (an MAOI) 2 days ago on her own after reading about it online. Vital signs show BP 148/92 mmHg, HR 112/min, RR 22/min. What is the most appropriate immediate next step in management?

Explanation

## Clinical Presentation Analysis This patient presents with classic **serotonin syndrome** triggered by concurrent use of sertraline (SSRI) and phenelzine (MAOI). The constellation of symptoms—agitation, tremor, hyperreflexia, hyperthermia (38.5°C), tachycardia, and hypertension—satisfies the **Hunter Criteria** for serotonin syndrome. ## Why Option D Is the Most Appropriate Immediate Next Step **Key Point:** This patient has **moderate** serotonin syndrome. She is hemodynamically stable (BP 148/92, HR 112) with no signs of impending cardiorespiratory collapse. The **most appropriate immediate next step** is: 1. **Discontinue all serotonergic agents** (sertraline + phenelzine) 2. **Obtain CK and urinalysis** to screen for rhabdomyolysis and myoglobinuria 3. **Initiate IV fluids** for hydration and renal protection 4. **Active cooling** (ice packs, cooling blankets) for hyperthermia This is the standard-of-care first step per Harrison's Principles of Internal Medicine (21e, Ch. 449) and UpToDate guidelines for moderate serotonin syndrome. ## Why Cyproheptadine (Option A) Is NOT the Immediate First Step **Clinical Pearl:** Cyproheptadine (a 5-HT2A antagonist) is used as an **adjunct** in moderate-to-severe serotonin syndrome, but it is **not the immediate first step**. The correct sequence is: - **First:** Supportive care (discontinue offending agents, IV fluids, cooling, benzodiazepines for agitation) - **Then:** Cyproheptadine if symptoms persist or worsen despite supportive measures Cyproheptadine is an **oral/NG-tube medication** — it cannot be given IV, limiting its utility in acute resuscitation. Supportive care is always initiated first. The 12 mg loading dose in Option A is also at the higher end of dosing (most guidelines cite 8 mg loading), though not strictly incorrect. **High-Yield:** The question asks for the **most appropriate immediate next step** — supportive care with labs and cooling is universally indicated first, before adding a serotonin antagonist. ## Why Options B and C Are Incorrect - **Option B (Intubation):** Not indicated — the patient is breathing spontaneously with RR 22/min and no signs of respiratory failure or severe rigidity requiring airway protection. - **Option C (Dantrolene):** Dantrolene is used for **Neuroleptic Malignant Syndrome (NMS)** and **malignant hyperthermia**, NOT serotonin syndrome. This is a classic distractor. ## Serotonin Syndrome vs. NMS | Feature | Serotonin Syndrome | NMS | |---------|-------------------|-----| | **Onset** | Hours to days | Days to weeks | | **Trigger** | Serotonergic drugs (SSRI, MAOI) | Antipsychotics | | **Clonus/Hyperreflexia** | Present | Absent | | **GI symptoms** | Diarrhea common | Constipation common | | **First-line Rx** | Supportive care ± cyproheptadine | Supportive care ± dantrolene | ## Management Algorithm ``` Moderate Serotonin Syndrome → Discontinue serotonergic agents → IV fluids + active cooling → Check CK, urinalysis, BMP → Benzodiazepines for agitation/myoclonus → If refractory: add cyproheptadine 8 mg PO/NG, then 4 mg q4–6h → ICU if severe (rigidity, temp >41°C, hemodynamic instability) ``` **Key Point:** Rhabdomyolysis is a serious complication of serotonin syndrome. Early CK and urinalysis allow timely aggressive IV hydration and urine alkalinization to prevent acute kidney injury. [cite: Harrison 21e Ch. 449; Boyer EW & Shannon M, NEJM 2005]